Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:YMTX

Yumanity Therapeutics (YMTX) Stock Price, News & Analysis

Yumanity Therapeutics logo

About Yumanity Therapeutics Stock (NASDAQ:YMTX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.56
$1.89
52-Week Range
N/A
Volume
6,790 shs
Average Volume
473,083 shs
Market Capitalization
$7.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive YMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Yumanity Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

YMTX Stock News Headlines

JSPR Jasper Therapeutics, Inc.
Cara Therapeutics Inc CARA
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
Yumanity Therapeutics Inc.
See More Headlines

YMTX Stock Analysis - Frequently Asked Questions

Yumanity Therapeutics, Inc. (NASDAQ:YMTX) released its quarterly earnings data on Thursday, August, 12th. The company reported ($1.03) EPS for the quarter, missing analysts' consensus estimates of ($0.84) by $0.19. The business earned $2.11 million during the quarter, compared to analysts' expectations of $2.27 million. Yumanity Therapeutics had a negative net margin of 660.61% and a negative trailing twelve-month return on equity of 263.34%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Yumanity Therapeutics investors own include NIO (NIO), Arch Therapeutics (ARTH), Aytu BioPharma (AYTU), Clarus Therapeutics (CRXTQ), Ford Motor (F), Novavax (NVAX) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
8/12/2021
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:YMTX
CIK
1445283
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$39.50 million
Net Margins
-660.61%
Pretax Margin
-660.61%

Debt

Sales & Book Value

Annual Sales
$4.84 million
Price / Cash Flow
N/A
Book Value
$2.28 per share
Price / Book
N/A

Miscellaneous

Free Float
9,504,000
Market Cap
$7.46 million
Optionable
Not Optionable
Beta
0.32
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:YMTX) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners